Fox Run Management, L.L.C. Coherus Bio Sciences, Inc. Transaction History

Fox Run Management, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$3.74 - $5.45 $66,534 - $96,955	17,790 New	17,790 $66,000
Q4 2018 Jan 15, 2019	SELL	$8.65 - $16.28 $108,038 - $203,337	-12,490 Closed	0 $0
Q3 2018 Oct 05, 2018	SELL	$14.45 - $20.25 $94,055 - $131,807	-6,509 Reduced 34.26%	12,490 $206,000
Q2 2018 Jul 17, 2018	BUY	$10.25 - $17.45 $194,739 - $331,532	18,999 New	18,999 $266,000
Q1 2018 Apr 17, 2018	SELL	$9.1 - $13.7 $236,145 - $355,515	-25,950 Closed	0 $0
Q4 2017 Jan 18, 2018	BUY	$8.35 - $14.4 $216,682 - $373,680	25,950	25,950 $228,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $115M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.